Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
paresh_vyas

Prof Paresh Vyas has just been awarded a Grant from Leukaemia and Lymphoma Research  - A first-in-human, first-in-class Phase I dose escalation trial of Humanized Anti-CD47 Monoclonal Antibody Hu5F9-G4 in Acute Myeloid Leukaemia (AML).

Paresh says – “Leukaemia and Lymphoma Research is one of the biggest charitable funders of haematology research in the UK.  They have awarded the MRC Molecular Haematology Unit a grant of £300 000 to conduct a first-in-class first in man clinical trial of a novel immunotherapeutic monoclonal antibody, directed against the cell surface protein CD47, to treat patients with relapsed/refractory Acute Myeloid Leukaemia.  This is an innovative therapeutic that aims to harness the body’s own immune system to fight cancer.  The work is a an exciting collaboration with the Oxford Early Phase Oncology Clinical Trials Unit, Stanford University and the UK AML Clinical Trials Group.“

Similar stories

Spin-out company Alethiomics launches

The enterprise will focus on developing targeted therapies for a specific family of blood cancers.

Study links the onset of circulation to changes in metabolism affecting blood stem cell development

A new paper published in Cell Reports by the de Bruijn Group indicates that the onset of circulation triggers a metabolic switch associated with the maturation of haematopoietic stem cells.

Interview with Excellence Award winner Dr Susan Shapiro

A member of the Oxford Centre For Haematology, Dr Shapiro, was recently interviewed by the Royal College of Pathologists.

Mohsin Badat receives ASH-BSH Abstract Achievement Award

Dr Mohsin Badat, a Clinical Training Research Fellow from the Higgs and Davies Groups has been awarded the ASH-BSH Abstract Achievement Award by the American Society of Haematology and the British Society of Haematology.

Iron integral to the development of life on Earth – and the possibility of life on other planets

A collaboration between researchers at the MRC WIMM and Department of Earth Sciences uncovers the importance of iron for the development of complex life on Earth.

Strong cytotoxic T cell responses to an internal viral component are associated with mild COVID-19 disease

Study from the Dong Group reveals key differences in the adaptive immune responses of patients with mild vs. severe COVID-19, highlighting a potential new vaccine target.